Invasive Fungal Sinusitis

IFS Overview - Fungal Foes

• Life-threatening fungal infection with invasion of sinonasal mucosa, submucosa, vasculature, and bone.
• Primarily affects immunocompromised individuals (diabetes, neutropenia, steroid use).
• Key Fungal Agents:
  • Aspergillus spp. (commonest worldwide)
  • Mucorales (e.g., Rhizopus, Mucor; prominent in India, esp. post-COVID)
• Major Clinical Types:
  • Acute Invasive Fungal Sinusitis (AIFS): Rapid onset (<4 weeks), angioinvasion, necrosis.
  • Chronic Invasive Fungal Sinusitis (CIFS): Indolent (>12 weeks), may involve granulomas or be non-granulomatous.

⭐ Acute Invasive Fungal Sinusitis (AIFS) is a medical emergency requiring prompt intervention.

## IFS Overview - Fungal Foes

• Life-threatening fungal infection with invasion of sinonasal mucosa, submucosa, vasculature, and bone.
• Primarily affects immunocompromised individuals (diabetes, neutropenia, steroid use).
• Key Fungal Agents:
  • Aspergillus spp. (commonest worldwide)
  • Mucorales (e.g., Rhizopus, Mucor; prominent in India, esp. post-COVID)
• Major Clinical Types:
  • Acute Invasive Fungal Sinusitis (AIFS): Rapid onset (<4 weeks), angioinvasion, necrosis.
  • Chronic Invasive Fungal Sinusitis (CIFS): Indolent (>12 weeks), may involve granulomas or be non-granulomatous.

⭐ Acute Invasive Fungal Sinusitis (AIFS) is a medical emergency requiring prompt intervention.

(image)[2931967b-4999-43ac-b7fc-7221e1105eb7]

Risk Factors & Pathogens - Susceptible Sinuses

• Key Risk Factors: Severe immunocompromise.
  • Diabetes Mellitus (esp. DKA 📌)
  • Hematological malignancies (leukemia, lymphoma)
  • Neutropenia (ANC <500/µL)
  • Solid organ/stem cell transplant recipients
  • Prolonged high-dose corticosteroids
  • HIV/AIDS (CD4 <200 cells/µL)
• Common Pathogens:
  • Mucorales (e.g., Rhizopus oryzae, Mucor): Broad, non-septate hyphae, right-angle branching. Angioinvasion common.

    ⭐ Mucormycosis shows a strong predilection for patients with diabetic ketoacidosis (DKA) due to the acidic, glucose-rich environment.

  • Aspergillus spp. (e.g., A. fumigatus, A. flavus): Septate hyphae, acute (45°) angle branching.
• Sinus Predilection:
  • Maxillary (most common), Ethmoid, Sphenoid, Frontal.
  • Typically unilateral onset.

Clinical Picture - Sinister Signs

• Rapidly progressive symptoms (hours to days).
• Severe facial pain, headache, facial numbness (CN V).
• Periorbital edema, proptosis, ophthalmoplegia (CN III, IV, VI), diplopia.
• Acute visual loss (CN II).
• Nasal:
  • Black necrotic eschar on turbinates/septum.
  • Purulent, bloody, or foul discharge.
• Palatal or gingival necrosis (black lesions).
• Fever (often low-grade/absent).
• Altered mental status (late, poor prognosis).

⭐ The presence of a black necrotic eschar in the nasal cavity or on the palate is a hallmark sign highly suggestive of mucormycosis.

Diagnosis & Imaging - Unmasking Invaders

• Nasal Endoscopy: Crucial first step. Look for pale, dusky, or black necrotic tissue (turbinates, septum), eschar formation. Insensitivity of mucosa.
• Biopsy (Urgent & Multiple): From suspicious areas. Send for:
  • HPE (Frozen section if available): Shows hyphal invasion of tissue, vessels.

  ⭐ Histopathological examination (HPE) of a biopsy specimen demonstrating fungal hyphae invading tissue is the gold standard for diagnosing IFS.

  • Microbiology: KOH mount (rapid), fungal culture & sensitivity.
• Imaging:
  • CECT (PNS, Orbit, Brain): Initial. Bone erosion/destruction, unilateral opacification, perisinus fat stranding.
  • MRI with Gadolinium (PNS, Orbit, Brain): Superior for soft tissue, early intracranial/orbital spread, cavernous sinus thrombosis. T2 hypointensity (fungal elements), variable enhancement.

Treatment & Prognosis - Fungus Fightback

• Core Strategy: Aggressive, multimodal.
  • Surgical Debridement: Prompt, wide excision of necrotic tissue.
  • Systemic Antifungals: Liposomal Amphotericin B (L-AMB); Voriconazole/Posaconazole as alternatives.
  • Control Predisposing Factors: E.g., manage diabetes, neutropenia.
• Prognosis: Guarded. Early, aggressive intervention is key.
  • Mortality: High; depends on host immunity, disease extent.
  • Poor Prognosis: Intracranial/orbital spread, delayed Rx.

⭐ Liposomal Amphotericin B is generally preferred over conventional Amphotericin B for treating IFS due to its improved renal safety profile and better tissue penetration.

High‑Yield Points - ⚡ Biggest Takeaways

• Affects immunocompromised patients, especially with uncontrolled diabetes or neutropenia.
• Mucor and Aspergillus species are the most common causative fungi.
• Classic sign: black necrotic eschar in the nasal cavity or palate.
• Characterized by rapid angioinvasion causing tissue necrosis and orbital/intracranial spread.
• Diagnosis: Biopsy for histopathology (hyphal invasion) is key, with CT/MRI imaging.
• Treatment: Urgent, aggressive surgical debridement plus systemic IV Amphotericin B.
• Carries high mortality despite prompt, aggressive management.